Cancer Screening

Certain lung cancer screening guidelines appear to undercount Black people, thus contributing to disparities in screening and treatment, according to study results published in Journal of Thoracic Oncology.

A novel blood-based assay demonstrated the ability to detect five cancer types up to 4 years earlier than current screening methods, according to study results published in Nature Communications.

The COVID-19 pandemic has caused disruptions in the delivery of medical care across specialties.

Colorectal cancer screening rates have significantly decreased in recent years among at-risk populations, and COVID-19 has exacerbated this decline, according to a recent analysis. It was the top story in gastroenterology last week.

Annual mammography beginning at age 40 or 41 years led to a reduction in breast cancer mortality while adding little to the burden of overdiagnosis, according to results of a randomized study in the U.K. published in The Lancet Oncology.

Mailed stool blood tests and follow-up phone calls are examples of effective strategies that increased colorectal cancer screening among African Americans, according to findings of a systematic review.

New model estimates demonstrate the long-term benefits of prostate cancer screening and “suggest that the balance of benefits and harms of screening may be more favorable than is generally appreciated,” experts wrote in The New England Journal of Medicine.

Cancer-related patient encounters have decreased significantly as a result of the COVID-19 pandemic, according to trends observed in the COVID and Cancer Research Network and reported in JCO: Clinical Cancer Informatics.

An updated guideline issued by the American Cancer Society recommends cervical cancer screening with the HPV test every 5 years from age 25 years to 65 years.

Twenty years ago, digital mammography seemed poised to take its place at the forefront of breast cancer imaging.